Summary
Lawrence Marcin is a medicinal chemist and discovery program leader with over two decades of experience advancing small-molecule therapeutics from hit validation to preclinical candidate selection. Currently Vice President, Chemistry and Site Lead at Biohaven, he oversees a bifunctional extracellular protein degradation platform and manages research operations in New Haven. His career spans leadership roles at Valo, FORMA, and Bristol-Myers Squibb where he led oncology and neuroscience programs, integrated ML-driven molecular design with traditional medicinal chemistry, and delivered candidates including a GluN2B negative allosteric modulator. Known for scaling discovery teams and coordinating CRO partnerships, he also has a strong synthetic chemistry pedigree from a PhD at UIUC and a NIH postdoc at Harvard. A pragmatic strategist, he combines hands-on chemistry innovation with program-level budgeting, out-licensing experience, and a penchant for leveraging computational tools to accelerate drug discovery.
12 years of coding experience
12 years of employment as a software developer
Bachelor of Science - BS, Chemistry, Bachelor of Science - BS, Chemistry at Penn State University
University of Illinois Urbana-Champaign